▲HeadlineSift
Health & WellnessGlobal (GL)

stat+: roche gets a lung cancer win with its kras drug divarasib

First reported: 23h agoUpdated: 23h ago1 source covering

⚠️ Content Notice

This story relates to health or medical topics. HeadlineSift's AI-generated summaries are for informational purposes only and do not constitute medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional for medical decisions.

AI analysis is pending for this story. Check back soon.


Sources & Attribution

STAT News
861 article

Original Articles (1)

STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
STAT News·Adam Feuerstein and Andrew Joseph·Monday, October 26, 2026 11:17 PM
Read original →